Open Access

[Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells

  • Authors:
    • Ludovica Taglieri
    • Francesca De Luliis
    • Anna Giuffrida
    • Sabrina Giantulli
    • Ida Silvestri
    • Susanna Scarpa
  • View Affiliations

  • Published online on: July 3, 2023     https://doi.org/10.3892/ol.2023.13938
  • Article Number: 352
  • Copyright : © Taglieri et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

August-2023
Volume 26 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Taglieri L, De Luliis F, Giuffrida A, Giantulli S, Silvestri I and Scarpa S: [Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells. Oncol Lett 26: 352, 2023
APA
Taglieri, L., De Luliis, F., Giuffrida, A., Giantulli, S., Silvestri, I., & Scarpa, S. (2023). [Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells. Oncology Letters, 26, 352. https://doi.org/10.3892/ol.2023.13938
MLA
Taglieri, L., De Luliis, F., Giuffrida, A., Giantulli, S., Silvestri, I., Scarpa, S."[Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells". Oncology Letters 26.2 (2023): 352.
Chicago
Taglieri, L., De Luliis, F., Giuffrida, A., Giantulli, S., Silvestri, I., Scarpa, S."[Retracted] Resistance to the mTOR inhibitor everolimus is reversed by the downregulation of survivin in breast cancer cells". Oncology Letters 26, no. 2 (2023): 352. https://doi.org/10.3892/ol.2023.13938